Chlamydia Tests - Medical Devices Pipeline Assessment, 2017

  • ID: 4296702
  • Report
  • 100 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Beckman Coulter Inc
  • bioMerieux S.A.
  • Boditech Med Inc
  • DiaSorin S.p.A
  • Ellume
  • ProCelo AS
  • MORE
Chlamydia Tests - Medical Devices Pipeline Assessment, 2017

Summary

The author's Medical Devices sector report, “Chlamydia Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Chlamydia Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Chlamydia Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Chlamydia Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Chlamydia Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry

Reasons to buy

The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Chlamydia Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Beckman Coulter Inc
  • bioMerieux S.A.
  • Boditech Med Inc
  • DiaSorin S.p.A
  • Ellume
  • ProCelo AS
  • MORE
1 Table of Contents
2 Introduction
2.1 Chlamydia Tests Overview
3 Products under Development
3.1 Chlamydia Tests - Pipeline Products by Stage of Development
3.2 Chlamydia Tests - Pipeline Products by Territory
3.3 Chlamydia Tests - Pipeline Products by Regulatory Path
3.4 Chlamydia Tests - Pipeline Products by Estimated Approval Date
4 Chlamydia Tests - Pipeline Products under Development by Companies
4.1 Chlamydia Tests Companies - Pipeline Products by Stage of Development
4.2 Chlamydia Tests - Pipeline Products by Stage of Development
5 Chlamydia Tests Companies and Product Overview
5.1 Beckman Coulter Inc Company Overview
5.1.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 bioMerieux S.A. Company Overview
5.2.1 bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Boditech Med Inc Company Overview
5.3.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 DiaSorin S.p.A Company Overview
5.4.1 DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview
5.5 Ellume Company Overview
5.5.1 Ellume Pipeline Products & Ongoing Clinical Trials Overview
5.6 Genome Diagnostics Pvt. Ltd. Company Overview
5.6.1 Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.7 Molbio Diagnostics Pvt. Ltd. Company Overview
5.7.1 Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.8 ProCelo AS Company Overview
5.8.1 ProCelo AS Pipeline Products & Ongoing Clinical Trials Overview
5.9 Queensland University of Technology Company Overview
5.9.1 Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.10 Quidel Corp Company Overview
5.10.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview
5.11 Sansure Biotech Inc Company Overview
5.11.1 Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Chlamydia Tests - Recent Developments
6.1 May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors
6.2 May 16, 2017: Akers Biosciences Announces Q1 2017 Earnings
6.3 May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017
6.4 May 10, 2017: Meridian Bioscience Engages Korn Ferry to Conduct CEO Search as John A. Kraeutler Announces Plans to Retire
6.5 May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter
6.6 Apr 27, 2017: Meridian Bioscience Reports Second Quarter 2017 Operating Results
6.7 Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results
6.8 Apr 23, 2017: BD Announces Appointment Of Tom Polen As President
6.9 Apr 20, 2017: bioMerieux - First-Quarter 2017 Business Review
6.10 Apr 11, 2017: Akers Bioscience: Financial Results for the Year Ended December 31, 2016
6.11 Apr 11, 2017: Akers Biosciences Reports Earnings for Fiscal Year 2016
6.12 Mar 30, 2017: Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016
6.13 Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management
6.14 Mar 21, 2017: Retractable Technologies Announces Litigation Updates
6.15 Mar 09, 2017: Alere Provides Update on Arriva Medical
6.16 Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results
6.17 Feb 02, 2017: BD Announces Results For 2017 First Fiscal Quarter
6.18 Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017
6.19 Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories
6.20 Jan 19, 2017: bioMerieux - Fourth-Quarter 2016 Business Review
6.21 Jan 13, 2017: ProteoMediX receives ISO 13485:2012 Certification
6.22 Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016
6.23 Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team
6.24 Jan 04, 2017: Alere Laboratory Receives ABFT Accreditation
6.25 Jan 04, 2017: Alere Provides Update on Arriva Medical
6.26 Dec 28, 2016: Alere Provides Update on Arriva Medical
6.27 Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors
6.28 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe
6.29 Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm
6.30 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition
6.31 Nov 14, 2016: Akers Biosciences Announces Q3 Earnings
6.32 Nov 10, 2016: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results
6.33 Nov 10, 2016: Diasorin Group Reports Continued Growth In Revenues And Profitability In The Third Quarter 2016
6.34 Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux
6.35 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results
6.36 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance
6.37 Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016
6.38 Oct 26, 2016: Quidel Reports Third Quarter 2016 Financial Results
6.39 Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016
6.40 Oct 18, 2016: Meridian Bioscience Comments on Preliminary Fiscal 2016 Operating Results and Provides Fiscal 2017 Revenue and Earnings Guidance
6.41 Oct 03, 2016: Bioline is Certified to the ISO 13485 Quality Standard
6.42 Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results
6.43 Aug 31, 2016: bioMerieux - First-Half 2016 Results
6.44 Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results
6.45 Aug 11, 2016: Akers Biosciences Announces H1 and Q2 2016 Earnings
6.46 Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results
6.47 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter
6.48 Aug 04, 2016: Diasorin Group Revenues And EBITDA Reached Record highs In the Second Quarter 2016
6.49 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors
6.50 Jul 28, 2016: Cepheid Reports Second Quarter 2016 Results
6.51 Jul 28, 2016: Meridian Bioscience Reports Third Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Updates Fiscal 2016 Guidance
6.52 Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016
6.53 Jul 27, 2016: Quidel Reports Second Quarter 2016 Financial Results
6.54 Jul 18, 2016: bioMerieux - Second-Quarter 2016 Business Review
7 Appendix
7.1 Methodology

List of Tables
Table 1: Chlamydia Tests - Pipeline Products by Stage of Development
Table 2: Chlamydia Tests - Pipeline Products by Territory
Table 3: Chlamydia Tests - Pipeline Products by Regulatory Path
Table 4: Chlamydia Tests - Pipeline Products by Estimated Approval Date
Table 5: Chlamydia Companies - Pipeline Products by Stage of Development
Table 6: Chlamydia Tests - Pipeline Products by Stage of Development
Table 7: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Diagnostic Test - Chlamydia - Product Status
Table 9: Diagnostic Test - Chlamydia - Product Description
Table 10: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
Table 11: NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Status
Table 12: NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Description
Table 13: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 14: AFIAS-6 Chlamydia - Product Status
Table 15: AFIAS-6 Chlamydia - Product Description
Table 16: DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview
Table 17: LIAISON - Chlamydia P. IgA Assay - Product Status
Table 18: LIAISON - Chlamydia P. IgA Assay - Product Description
Table 19: LIAISON - Chlamydia P. IgG Assay - Product Status
Table 20: LIAISON - Chlamydia P. IgG Assay - Product Description
Table 21: LIAISON XL - Chlamydia Pneumoniae Assay - Product Status
Table 22: LIAISON XL - Chlamydia Pneumoniae Assay - Product Description
Table 23: Ellume Pipeline Products & Ongoing Clinical Trials Overview
Table 24: ESP-Based Diagnostic Test - Chlamydia - Product Status
Table 25: ESP-Based Diagnostic Test - Chlamydia - Product Description
Table 26: Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Chlamydia trachomatis Real Time PCR Kit - Product Status
Table 28: Chlamydia trachomatis Real Time PCR Kit - Product Description
Table 29: Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Truenat Chlamydia Assay - Product Status
Table 31: Truenat Chlamydia Assay - Product Description
Table 32: ProCelo AS Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Diagnostic Kit - Chlamydia Pneumonia - Product Status
Table 34: Diagnostic Kit - Chlamydia Pneumonia - Product Description
Table 35: Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Chlamydia-induced Infertility Diagnostic Assay - Product Status
Table 37: Chlamydia-induced Infertility Diagnostic Assay - Product Description
Table 38: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 39: IsoAmp Assay - Chlamydia Trachomatis - Product Status
Table 40: IsoAmp Assay - Chlamydia Trachomatis - Product Description
Table 41: Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Chlamydia Pneumoniae DNA Fluorescence Diagnostic Kit - Product Status
Table 43: Chlamydia Pneumoniae DNA Fluorescence Diagnostic Kit - Product Description
Table 44: Glossary

List of Figures
Figure 1: Chlamydia Tests - Pipeline Products by Stage of Development
Figure 2: Chlamydia - Pipeline Products by Territory
Figure 3: Chlamydia Tests - Pipeline Products by Regulatory Path
Figure 4: Chlamydia Tests - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Beckman Coulter Inc
  • bioMerieux S.A.
  • Boditech Med Inc
  • DiaSorin S.p.A
  • Ellume
  • Genome Diagnostics Pvt. Ltd.
  • Molbio Diagnostics Pvt. Ltd.
  • ProCelo AS
  • Queensland University of Technology
  • Quidel Corp
  • Sansure Biotech Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll